Interestingly, metformin treatment significantly decreased TNF-α mRNA and blunted nitrotyrosine levels, and modestly reduced immune cell infiltration in Ob-NAFLD. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.